|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.360 USD | +2.61% |
|
+1.29% | +31.11% |
| May. 13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| May. 13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 2026-06-30 | 2026-07-01 | 2026-07-02 | 2026-07-06 | 2026-07-07 | |
|---|---|---|---|---|---|
| Last | $2.330 | $2.300 | $2.320 | $2.300 | $2.360 |
| Volume | 500,098 | 436,234 | 472,793 | 366,793 | 696,492 |
| Change | -0.85% | -1.29% | +0.87% | -0.86% | +2.61% |
| Opening | $2.360 | $2.310 | $2.300 | $2.310 | $2.310 |
| High | $2.360 | $2.335 | $2.355 | $2.350 | $2.385 |
| Low | $2.310 | $2.260 | $2.270 | $2.295 | $2.256 |
Performance
| 1 day | +2.61% | ||
| 1 week | +1.29% | ||
| Current month | +1.29% | ||
| 1 month | +18.59% | ||
| 3 months | +7.76% | ||
| 6 months | +32.58% | ||
| Current year | +31.11% | ||
| 1 year | +60.54% | ||
| 3 years | +31.11% | ||
| 5 years | +40.48% | ||
| 10 years | -63.18% |
Volumes
marketsDaily volume
696,492
Estimated daily volume
696,492
Avg. Volume 20 sessions
753,092
Daily volume ratio
0.92
Avg. Volume 20 sessions USD
1,777,297.12
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
190,149,075
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
182,775,482
Average Daily Capital Traded
0.93%
Indicators
Moving average 5 days
2.32
Moving average 20 days
2.154
Moving average 50 days
2.086
Moving average 100 days
2.324
Price spread / (MMA5)
-1.69%
Price spread / (MMA20)
-8.71%
Price spread / (MMA50)
-11.60%
Price spread / (MMA100)
-1.53%
STIM
RSI 9 days
63.46
RSI 14 days
61.59
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.61% | +1.29% | +60.54% | +31.11% | 190M | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,102B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 643B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| +0.74% | -2.07% | +27.62% | +22.57% | 336B | |
| -0.76% | +0.17% | +29.90% | +49.33% | 288B | |
| -1.27% | +4.08% | -25.78% | -39.02% | 222B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 199B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 169B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 137B | |
| Average | +0.79% | +1.59% | +30.30% | +51.24% | 354.53B | |
| Weighted average by Cap. | +1.41% | +1.86% | +41.96% | +87.58% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
b3469aec98d1b53bb586.Ez7hjMzoKHeLiX-Wxnt469UZpeZDPtsWz1tdfAtDKTE.Pgyb2L2-WRT5xyvBkR4ymZAg9bYlTe9f-igcMmg1SkdQe4fog9FANsztEA
| Date | Price | Volume | Total |
|---|---|---|---|
| 04:00:00 pm | 2.360 | 10,946 | 571,088 |
| 03:59:59 pm | 2.365 | 200 | 560,142 |
| 03:59:59 pm | 2.365 | 116 | 559,942 |
| 03:59:58 pm | 2.365 | 200 | 559,826 |
| 03:59:56 pm | 2.365 | 309 | 559,626 |
| 03:59:56 pm | 2.360 | 100 | 559,317 |
| 03:59:56 pm | 2.360 | 100 | 559,217 |
| 03:59:56 pm | 2.365 | 100 | 559,117 |
| 03:59:56 pm | 2.365 | 164 | 559,017 |
| 03:59:56 pm | 2.365 | 336 | 558,853 |
Course Extremes
| 1 week | 2.26 |  | 2.38 |
| 1 month | 1.96 | | 2.38 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.36 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +31.11% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
